Literature DB >> 12837968

Drug resistance mutations in HIV-1.

Richard T D'Aquila1, Jonathan M Schapiro, Françoise Brun-Vézinet, Bonaventura Clotet, Brian Conway, Lisa M Demeter, Robert M Grant, Victoria A Johnson, Daniel R Kuritzkes, Clive Loveday, Robert W Shafer, Douglas D Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12837968

Source DB:  PubMed          Journal:  Top HIV Med        ISSN： 1542-8826


× No keyword cloud information.
  33 in total

1.  Novel enzyme-linked minisequence assay for genotypic analysis of human immunodeficiency virus type 1 drug resistance.

Authors:  Wataru Sugiura; Kazunori Shimada; Masakazu Matsuda; Tomoko Chiba; Lay Myint; Aiko Okano; Kaneo Yamada
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.

Authors:  Rami Kantor; Robert W Shafer; Stephen Follansbee; Jonathan Taylor; David Shilane; Leo Hurley; Dong-Phuong Nguyen; David Katzenstein; W Jeffrey Fessel
Journal:  AIDS       Date:  2004-07-23       Impact factor: 4.177

3.  Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.

Authors:  Karen Moeremans; Lieven Annemans; Mickael Löthgren; Gabriele Allegri; Veronique Wyffels; Lindsay Hemmet; Karin Caekelbergh; Erik Smets
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.

Authors:  Andrew M Hill; Kelly Gebo; Lindsay Hemmett; Mickael Löthgren; Gabriele Allegri; Erik Smets
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.

Authors:  Rami Kantor; Robert W Shafer; David Katzenstein
Journal:  MedGenMed       Date:  2005-02-23

Review 6.  Genetic barriers to resistance and impact on clinical response.

Authors:  Andrew D Luber
Journal:  MedGenMed       Date:  2005-07-07

7.  Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.

Authors:  Janice D Pata; William G Stirtan; Steven W Goldstein; Thomas A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Pharmacokinetics of an indinavir-ritonavir-fosamprenavir regimen in patients with human immunodeficiency virus.

Authors:  Ighovwerha Ofotokun; Edward P Acosta; Jeffrey L Lennox; Yi Pan; Kirk A Easley
Journal:  Pharmacotherapy       Date:  2008-01       Impact factor: 4.705

9.  The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data.

Authors:  Rami Kantor; Robert W Shafer; David Katzenstein
Journal:  J Int AIDS Soc       Date:  2005-02-23       Impact factor: 5.396

10.  Genetic barriers to resistance and impact on clinical response.

Authors:  Andrew D Luber
Journal:  J Int AIDS Soc       Date:  2005-07-07       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.